Serum Institute of India gets DCGI nod for phase 2 and 3 human trials of Oxford vaccine candidate
As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.